Lumason Kit
Product Images NDC 0270-7099

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Lumason (NDC 0270-7099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bracco Diagnostics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lumason 5 Kit Market Unit Label (ce108503) Novaplus

Lumason injection powder, lyophilized, for suspension containing 60.7 mg sulfur hexafluoride and 25 mg lipid-type A per vial. The label specifies a kit of 5 single-use Lumason kits, each including one vial of lyophilized powder, a prefilled syringe with 5 mL Sodium Chloride 0.9% Injection for reconstitution, and one mini-spike. Manufactured for Bracco Diagnostics Inc. with detailed storage and reconstitution instructions is shown.*

FDA Label Image

Lumason Kit Box Label (cf108404) Novaplus

Lumason (sulfur hexafluoride lipid-type A microspheres) injection, powder, lyophilized, for suspension, 60.7 mg sulfur hexafluoride and 25 mg lipid-type A per vial by Bracco Diagnostics Inc. The label includes contents listing a vial of lyophilized powder and a prefilled syringe with 5 mL sodium chloride 0.9% injection as diluent. The packaging displays storage instructions and supplier information.*

FDA Label Image

Lumason Mp Box (cf116d02) Novaplus

Lumason 60.7 mg sulfur hexafluoride lipid-type A injection powder, lyophilized, for suspension vial label. Contains 20 single-use vials with 60.7 mg sulfur hexafluoride/25 mg lipid-type A per vial for intravenous or intravesical use after reconstitution. Manufactured by Bracco Diagnostics Inc. Includes storage instructions and detailed contents information.*

FDA Label Image

Lumason Vial Label Kit (ci108303) Novaplus

Lumason 60.7 mg sulfur hexafluoride per 25 mg lipid-type A per vial injection, powder, lyophilized for suspension. For intravenous or intravesical use after reconstitution with Sodium Chloride 0.9% Injection, USP (diluent). Labeler: Bracco Diagnostics Inc. The label includes usage instructions, storage conditions, expiration date, and lot number space.*

FDA Label Image

Lumason Vial Label Mp (ci116c02) Novaplus

Lumason 60.7 mg sulfur hexafluoride / 25 mg lipid-type A per vial injection, powder, lyophilized, for suspension. The label specifies use for intravenous or intravesical injection after reconstitution with sodium chloride. Storage instructions and reconstitution notes are also provided. The product is labeled by Bracco Diagnostics Inc.*

FDA Label Image

Empirical Formula 745

Chemical structure diagram depicting the molecular arrangement of the active ingredient sulfur hexafluoride in the Lumason injectable powder formulation by Bracco Diagnostics Inc.*

FDA Label Image

Empirical Formula 790 6

Chemical structure diagram showing the molecular formula of the active ingredient sulfur hexafluoride in Lumason injection, powder, lyophilized, for suspension by Bracco Diagnostics Inc.*

FDA Label Image

Figure1 Pack

An instructional black-and-white illustration shows a hand holding a saline solution bag labeled 'NaCl 0.9% USP' with a drip chamber below, and another hand connecting or adjusting a tube or vial beneath it. An arrow indicates downward motion, suggesting assembly or preparation of the intravenous setup.*

FDA Label Image

Figure1 Single

An instructional illustration showing two hands preparing a syringe. The top hand holds the syringe barrel, and the bottom hand holds the plunger, demonstrating a twisting or locking motion to connect the components. This image likely depicts part of the preparation process for Lumason injection.*

FDA Label Image

Figure2 Pack

Instructional illustration showing the assembly process of a syringe and vial adapter. One hand is holding a vial with an adapter attached, and the other hand is holding a syringe being connected to the vial adapter, indicating a step to prepare the Lumason injection for use.*

FDA Label Image

Figure2 Single

An instructional illustration showing a person's hands preparing a syringe by twisting or removing a cap, above a vial or container. This step is part of the preparation process for drug administration, likely associated with Lumason injection.*

FDA Label Image

Figure3 Pack

An instructional diagram showing how to connect a syringe to a vial or container. The illustration includes a hand holding the syringe attached to the vial, with an arrow indicating the direction of connection and the word 'click' to signify a locking or secure attachment. The number '3' is shown, suggesting a step in a multi-step process.*

FDA Label Image

Figure3 Single

An instructional diagram showing hands assembling a syringe and a vial or cartridge. One hand holds the syringe, while the other inserts or removes a component from the syringe's top, indicated by an arrow. This likely demonstrates a step in preparing an injection for the product Lumason (Sulfur Hexafluoride) injection, powder, lyophilized, for suspension.*

FDA Label Image

Figure4 Pack

An instructional diagram showing the preparation step for an injection, where one hand holds a vial and the other pushes down on a syringe plunger to draw liquid from the vial into the syringe. The vial is labeled with a symbol indicating fragility.*

FDA Label Image

Figure4 Single

Instructional diagram showing how to properly attach a syringe to a vial or container. The hand is holding the vial with the thumb pressing a part labeled 'click,' indicating the syringe is to be pressed or clicked into place upward. This image is likely part of preparation steps for Lumason injection, powder, lyophilized, for suspension, by Bracco Diagnostics Inc.*

FDA Label Image

Figure5 Pack

An instructional line drawing showing a hand holding a vial while a syringe is inserted into it. Arrows indicate the direction of syringe insertion and vial positioning. The number 5 appears in the lower right corner, suggesting a step in a multi-step procedure.*

FDA Label Image

Figure5 Single

An instructional illustration showing hands preparing an injection. One hand holds a syringe positioned to draw liquid from a vial held by the other hand below. The vial has a label with a pair of scissors icon. A downward arrow indicates the syringe is being inserted into the vial to withdraw the liquid.*

FDA Label Image

Figure6 Pack

An instructional illustration showing a hand holding a vial and inserting a syringe needle into the vial stopper, with a downward arrow indicating the needle is being pushed into the vial. This is part of medication preparation for Lumason injection, powder, lyophilized, for suspension by Bracco Diagnostics Inc.*

FDA Label Image

Figure6 Single

An instructional black-and-white illustration showing a hand holding a syringe and vial. The syringe is being drawn upward from the vial, indicated by vertical arrows. The image is labeled with the number 6, suggesting a step in a multi-step preparation or administration procedure.*

FDA Label Image

Figure7 Pack

Illustration showing two hands preparing an injection by connecting a vial or syringe to another container. One hand holds the upper container, while the other hand secures the lower part, with an arrow indicating a twisting or turning motion. Number 7 is visible, suggesting it is part of a step-by-step instructional sequence.*

FDA Label Image

Figure7 Single

An instructional illustration showing a hand holding a vial and another hand holding a syringe, with an arrow indicating the syringe plunger being pulled down to withdraw liquid from the vial. The image is related to the preparation of Lumason, an intravenous or intravesical injection of sulfur hexafluoride powder for suspension.*

FDA Label Image

Figure8 Single

An instructional illustration showing hands preparing a syringe from a vial. The image demonstrates twisting or attaching a component of the syringe to the vial, labeled as step 8 in the process.*

FDA Label Image

Glass Vial Spike Labels

Illustration showing packaging contents for Lumason injection, including 20 glass vials, 20 mini-spikes, and 20 peel-off syringe labels designed for preparing the powder for suspension.*

FDA Label Image

Glass Vial Spike Syringe And Rod

Illustration showing components of Lumason injection: a glass vial containing the powder, a prefilled syringe with diluent and its plunger rod, and a mini-spike device used for administration preparation.*

FDA Label Image

Novaplus Logo (Novaplus Logo)

FDA Label Image

Sulfur Hexafluoride Chemical Structure

Chemical structure of Sulfur Hexafluoride, the active ingredient in Lumason injection, powder, lyophilized, for suspension. The structure shows a sulfur atom centrally bonded to six fluorine atoms in an octahedral arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.